NASDAQ:ANTH

Anthera Pharmaceuticals Stock Signals

etoro logo Buy ANTH
*Your capital is at risk
$0.0010
+0 (+0%)
At Close: Jun 22, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Anthera Pharmaceuticals Inc

General

Signal Type Signal Value Data
Score 0.000 105 days ( -99,900.00 %
Last Price $0.0010 0 %
Performance History
7 Days
$0.0010 $0.0010
0%
30 Days
$0.0001 $0.0010
900.00%
12 Mos
$0.0001 $0.0010
900.00%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 29.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0010 - $0.0010
Trend - 3 mos 423.42 % High Width: 291.75 %
Pred. range - 3 mos $0.0014 - $0.0053 Low 35.38 % - 430.34 %
Volume Direction Sell High Volume: 234 · Direction: 0
Pivot Short Sell Very Low Jun 18, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 60.24
Signal Type Signal Value Importance Data
Trend - 12 mos 18.04 % Very High Width: 1,427.90 %
Pred. range - 12 mos $0.0000864167537 - $0.0013 High -91.36 % - 32.04 %
Short MA 12 mos Sell Very High Jan 13, 2026 - 110 days
Long MA 12 mos Buy Very High Mar 17, 2026 - 67 days
Short/Long MA 12 mos Buy Very High Apr 02, 2026 - 55 days
Pivot Long Sell Low Jun 18, 2026 - 2 days
RSI Long Pivot Signal Sell Low Nov 30, -0001 - N/A days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ANTHERA PHARMACEUTICALS INC
Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE